- ►annals.org [PDF] WF Clark, AK Stewart, GA Rock, M Sternbach, … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Two small, randomized trials provide conflicting evidence about the
benefits of plasma exchange for patients with acute renal failure at the onset
of multiple myeloma. Objective: To assess the effect of 5 to 7 plasma ... Cited by 55 - Related articles - All 4 versions
- ►asnjournals.org CA Hutchison, P Cockwell, S Reid, K Chandler … - Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol Of patients with newly diagnosed multiple myeloma, approximately 10% have
dialysis-dependent acute renal failure, with cast nephropathy, caused by
monoclonal free light chains (FLC). Of these, 80 to 90% require long-term ... Cited by 41 - Related articles - BL Direct - All 6 versions
P Zucchelli, S Pasquali, L Cagnoli, G Ferrari - Kidney Int, 1988 - nature.com Controlled plasma exchange trial in acute renal failure due to multiple myeloma.
We studied 29 patients affected by acute renal failure due to multiple myeloma
with Bence-Jones proteinuria > 1 g/day to evaluate the effectiveness of ... Cited by 110 - Related articles - All 3 versions
C Cserti, R Haspel, C Stowell, W Dzik - Transfusion, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 13 - Related articles - BL Direct - All 4 versions
N Leung, MA Gertz, SR Zeldenrust, SV … - Kidney International, 2008 - nature.com Cast nephropathy is the most common cause of renal disease in multiple myeloma,
however, treatment with plasma exchange remains controversial even after 3
randomized controlled studies. We sought to determine the importance of ... Cited by 12 - Related articles - BL Direct - All 4 versions
MA Gertz - Leukemia & Lymphoma, 2007 - informahealthcare.com The management of renal failure in patients with newly-diagnosed multiple
myeloma remains an ongoing challenge for practicing clinicians. In this issue of
Leukemia and Lymphoma, the Greek Myeloma Study Group reports an incidence ... Cited by 14 - Related articles - BL Direct - All 7 versions
J Blade, P Fernandez-Llama, F Bosch, J … - Archives of Internal Medicine, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 137 - Related articles - BL Direct - All 4 versions
WJ Johnson, RA Kyle, AA Pineda, PC O'Brien, … - Archives of Internal Medicine, 1990 - archinte.highwire.org \s=b\The aims of this study were to examine in a prospective, randomized trial
the efficacy of plasmapheresis in preventing irreversible renal failure in
patientswith multiple myeloma and to study the renal biopsy tissues from ... Cited by 131 - Related articles - All 4 versions
R Torra, J Blade - British Journal of Huematology, 1995 - interscience.wiley.com Summary. From January 1982 to December 1993, 30 patients with multiple myeloma
(MM) required haemodialysis (HD) at our institution. The subgroup of 20 patients
who survived more than 2 months on HD is the subject of this study. Four ... Cited by 47 - Related articles - BL Direct - All 3 versions
A Korzets, F Tam, G Russell, J Feehally, J … - American journal of kidney diseases: the official …, 1990 - ncbi.nlm.nih.gov A study in 10 patients (eight male, two female; mean age 61.9 +/- 10.7 years)
suffering from multiple myeloma (MM) and end-stage renal failure (ESRF) is
detailed. Continuous ambulatory peritoneal dialysis (CAPD) was the ... Cited by 30 - Related articles - All 4 versions
